Hims & Hers Health (HIMS) Appoints Anja Manuel to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
Citi Reiterates Buy Rating on Hims and Hers (HIMS)
May 20, 2024 11:49 AM EDTCiti analyst Daniel Grosslight reiterated a Buy rating and $16.00 price target on Hims and Hers (NYSE: HIMS)
The analyst comments "As widely anticipated, HIMS launched its GLP-1 offering this morning, which we think will significantly increase the interest in its weight loss offering.... More
